Yost is warning the companies to not tell consumers that the drugs have been approved by the Food & Drug Administration.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Ohio Attorney General Dave Yost has sent letters to 14 medical spas throughout the state warning them to stop making false or ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

14 medical spas across the state were warned to stop making false or misleading claims regarding customized versions of ...

CLEVELAND, Ohio – The Ohio attorney general’s office is warning medical spas ... of popular weight-loss drugs. The custom-made variations, called compounded drugs, are made of semaglutide ...

1 Multiple trials, including hundreds of obese/overweight women in the menopausal/postmenopausal age group, reflect weight loss of at least 5% with three months of semaglutide treatment.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss. The analysis comes from long-term ...

Semaglutide ... reach their target weight. The study did have some limitations, noted researcher Etminan. Those included the fact that it could not verify hair loss through medical records ...